EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson’s Disease

Alfonso E Martinez-Nunez, Peter A LeWitt

Journal of Parkinson’s Disease · 17.04.2023 · 13 (4) · 441-451

DOI: 10.3233/jpd-230055 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Parkinson’s Disease, online erschienen am 05.05.2023. Verfasst von Alfonso E Martinez-Nunez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Henry Ford Hospital, Detroit, MI, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with Parkinson’s disease often suffer from OFF symptoms disrupting their daily routines and adding to disabilities. Despite polypharmacy and adjustments to medication schedules, they often do not experience consistent relief from their motor symptoms. As the disease progresses, impaired gastric emptying may evolve, making it even more challenging for dopaminergic drugs to provide consistent results. This review focuses on a group of drugs that have the pharmacokinetic advantage of a much earlier onset of action by virtue of their non-oral routes of absorption. We compare the current marketed options: subcutaneous apomorphine, sublingual apomorphine, and inhaled levodopa. Subcutaneous apomorphine is the speediest to take effect, whereas sublingual apomorphine offers the longest clinical effect. Inhaled levodopa has the most favorable side effect profile among the three options. An inhaled form of apomorphine is currently under development, having passed safety and efficacy studies. Each of these drugs has unique characteristics for the user, including different side effect profiles and onset of action. The best choice for a patient will depend on individual needs and circumstances. In this review, we explore those nuances to allow clinicians to select the best option for their patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDrug-Related Side Effects and Adverse ReactionsHumansApomorphineLevodopaAntiparkinson AgentsDopamine Agonists

Stichwörter der Autor:innen

Parkinson’s diseaseapomorphinedopaminergic drugslevodopa

Substanzen

ApomorphineLevodopaAntiparkinson AgentsDopamine Agonists

Autor:innen und Institutionen

  • Department of Neurology, Henry Ford Hospital, Detroit, MI, USA.
  • Department of Neurology and Sastry Foundation Endowed Chair In Neurology, Wayne State University School of Medicine, Detroit, MI, USA.

Zitieren

APA

Martinez-Nunez, A. E., & LeWitt, P. A. (2023). Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson’s Disease. Journal of Parkinson’s Disease, 13(4), 441-451. https://doi.org/10.3233/jpd-230055

Vancouver

Martinez-Nunez AE, LeWitt PA. Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson’s Disease. Journal of Parkinson’s Disease. 2023;13(4):441-451. doi:10.3233/jpd-230055

BibTeX
@article{MartinezNunez2023,
  author = {Martinez-Nunez, Alfonso E and LeWitt, Peter A},
  title = {Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson’s Disease},
  journal = {Journal of Parkinson’s Disease},
  year = {2023},
  volume = {13},
  number = {4},
  pages = {441--451},
  doi = {10.3233/jpd-230055}
}
Kostenlos starten →